Increasing incidence of glioblastoma multiforme and meningioma, and decreasing incidence of Schwannoma (2000-2008): Findings of a multicenter Australian study
- PMID: 22276231
- PMCID: PMC3263004
- DOI: 10.4103/2152-7806.90696
Increasing incidence of glioblastoma multiforme and meningioma, and decreasing incidence of Schwannoma (2000-2008): Findings of a multicenter Australian study
Abstract
Background: The incidence of primary brain tumors by subtype is currently unknown in Australia. We report an analysis of incidence by tumor subtype in a retrospective multicenter study in the state of New South Wales (NSW) and the Australian Capital Territory (ACT), with a combined population of >7 million with >97% retention rate for medical care.
Methods: Data from histologically confirmed primary brain tumors diagnosed from January 2000 through December 2008 were weighted for patient outflow and data completeness, and age standardized and analyzed using joinpoint analysis.
Results: A significant increasing incidence in glioblastoma multiforme (GBM) was observed in the study period (annual percentage change [APC], 2.5; 95% confidence interval [CI], 0.4-4.6, n = 2275), particularly after 2006. In GBM patients in the ≥65-year group, a significantly increasing incidence for men and women combined (APC, 3.0; 95% CI, 0.5-5.6) and men only (APC, 2.9; 95% CI, 0.1-5.8) was seen. Rising trends in incidence were also seen for meningioma in the total male population (APC, 5.3; 95% CI, 2.6-8.1, n = 515) and males aged 20-64 years (APC, 6.3; 95% CI, 3.8-8.8). Significantly decreasing incidence trends were observed for Schwannoma for the total study population (APC, -3.5; 95% CI, -7.2 to -0.2, n = 492), significant in women (APC, -5.3; 95% CI, -9.9 to -0.5) but not men.
Conclusion: This collection is the most contemporary data on primary brain tumor incidence in Australia. Our registries may observe an increase in malignant tumors in the next few years that they are not detecting now due to late ascertainment. We recommend a direct, uniform, and centralized approach to monitoring primary brain tumor incidence by subtype, including the introduction of nonmalignant data collection.
Keywords: Australia; cancer; incidence; late ascertainment; primary brain tumor.
Figures




Comment in
-
Has the incidence of brain cancer risen in Australia since the introduction of mobile phones 29 years ago?Cancer Epidemiol. 2016 Jun;42:199-205. doi: 10.1016/j.canep.2016.04.010. Epub 2016 May 5. Cancer Epidemiol. 2016. PMID: 27156022
Similar articles
-
A multicenter study of primary brain tumor incidence in Australia (2000-2008).Neuro Oncol. 2011 Jul;13(7):783-90. doi: 10.1093/neuonc/nor052. Neuro Oncol. 2011. PMID: 21727214 Free PMC article.
-
Nonmalignant meningioma and vestibular schwannoma incidence trends in the United States, 2004-2017.Cancer. 2021 Oct 1;127(19):3579-3590. doi: 10.1002/cncr.33553. Epub 2021 Jun 23. Cancer. 2021. PMID: 34160068 Free PMC article.
-
Italian cancer figures, report 2012: Cancer in children and adolescents.Epidemiol Prev. 2013 Jan-Feb;37(1 Suppl 1):1-225. Epidemiol Prev. 2013. PMID: 23585445 English, Italian.
-
Recent incidence trend of elderly patients with glioblastoma in the United States, 2000-2017.BMC Cancer. 2021 Jan 12;21(1):54. doi: 10.1186/s12885-020-07778-1. BMC Cancer. 2021. PMID: 33430813 Free PMC article.
-
Global Trends in Incidence Rates of Primary Adult Liver Cancers: A Systematic Review and Meta-Analysis.Front Oncol. 2020 Feb 28;10:171. doi: 10.3389/fonc.2020.00171. eCollection 2020. Front Oncol. 2020. PMID: 32185125 Free PMC article.
Cited by
-
From signalling pathways to targeted therapies: unravelling glioblastoma's secrets and harnessing two decades of progress.Signal Transduct Target Ther. 2023 Oct 20;8(1):400. doi: 10.1038/s41392-023-01637-8. Signal Transduct Target Ther. 2023. PMID: 37857607 Free PMC article. Review.
-
A Cancer Research UK First Time in Human Phase I Trial of IMA950 (Novel Multipeptide Therapeutic Vaccine) in Patients with Newly Diagnosed Glioblastoma.Clin Cancer Res. 2016 Oct 1;22(19):4776-4785. doi: 10.1158/1078-0432.CCR-16-0506. Epub 2016 May 25. Clin Cancer Res. 2016. PMID: 27225692 Free PMC article. Clinical Trial.
-
Identification of MDK as a Hypoxia- and Epithelial-Mesenchymal Transition-Related Gene Biomarker of Glioblastoma Based on a Novel Risk Model and In Vitro Experiments.Biomedicines. 2024 Jan 1;12(1):92. doi: 10.3390/biomedicines12010092. Biomedicines. 2024. PMID: 38255198 Free PMC article.
-
Anoctamins and Calcium Signalling: An Obstacle to EGFR Targeted Therapy in Glioblastoma?Cancers (Basel). 2022 Nov 30;14(23):5932. doi: 10.3390/cancers14235932. Cancers (Basel). 2022. PMID: 36497413 Free PMC article. Review.
-
Validation of magnetic resonance imaging-based automatic high-grade glioma segmentation accuracy via 11C-methionine positron emission tomography.Oncol Lett. 2019 Oct;18(4):4074-4081. doi: 10.3892/ol.2019.10734. Epub 2019 Aug 8. Oncol Lett. 2019. PMID: 31516607 Free PMC article.
References
-
- Australian hospital statistics 2006-07. Health services series no. 31. Cat. no. HSE 55. Canberra: AIHW; 2008. Australian Institute of Health and Welfare.
-
- Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2004-2006. Hinsdale, IL: Central Brain Tumor Registry of the United States; 2010. CBTRUS.
-
- National Program of Cancer Registries Training Materials. Atlanta, Georgia: Department of Health and Human Services; 2004. Centres for Disease Control and Prevention. Data collection of primary central nervous system tumors.
-
- Christensen HC, Kosteljanetz M, Johansen C. Incidences of gliomas and meningiomas in Denmark, 1943 to 1997. Neurosurgery. 2003;52:1327–33. discussion 1333-24. - PubMed
-
- Clegg LX, Feuer EJ, Midthune DN, Fay MP, Hankey BF. Impact of reporting delay and reporting error on cancer incidence rates and trends. J Natl Cancer Inst. 2002;94:1537–45. - PubMed
LinkOut - more resources
Full Text Sources